financetom
Business
financetom
/
Business
/
Grifols Q2 Adjusted EBITDA, Revenue Rise; Dividend Payment Reinstated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Grifols Q2 Adjusted EBITDA, Revenue Rise; Dividend Payment Reinstated
Jul 29, 2025 11:17 AM

01:53 PM EDT, 07/29/2025 (MT Newswires) -- Grifols ( GRFS ) reported Q2 adjusted earnings before interest, taxes, depreciation and amortization

on Tuesday of 475 million euros ($548.5 million), up from 440.8 million euros a year earlier.

Analysts polled by FactSet expected 465 million euros.

Revenue in the quarter rose to 1.89 billion euros from 1.82 billion euros a year earlier.

Analysts polled by FactSet expected 1.89 billion euros.

The company reinstated a dividend payment at 0.15 euros a share.

Price: 10.14, Change: +0.05, Percent Change: +0.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Lucid Stock?
What's Going On With Lucid Stock?
Feb 28, 2025
Lucid Group Inc ( LCID ) shares are trading lower by 28% to $2.12 this week after the company reported fourth-quarter financial results. What To Know: Shares of Lucid dropped on Wednesday after the luxury EV maker reported fourth-quarter earnings and announced a leadership shakeup that raised concerns about its future direction. Despite posting a smaller-than-expected loss of 22 cents per...
Helix Acquisition to Merge With BridgeBio Oncology Therapeutics
Helix Acquisition to Merge With BridgeBio Oncology Therapeutics
Feb 28, 2025
09:36 AM EST, 02/28/2025 (MT Newswires) -- Helix Acquisition Corp. II ( HLXB ) and TheRas, which does business as BridgeBio Oncology Therapeutics, said Friday they have agreed to merge to form biopharmaceutical company BridgeBio Oncology Therapeutics. The combined company is expected to have an implied pro forma equity value of about $949 million at closing based on a share...
Sycamore closing in on Walgreens buyout, CNBC reports
Sycamore closing in on Walgreens buyout, CNBC reports
Feb 28, 2025
Feb 28 (Reuters) - Private equity firm Sycamore Partners is closing in to buy out Walgreens Boots Alliance ( WBA ), CNBC reported on Friday, citing sources. The company had been in talks to be taken private by Sycamore since December, according to media reports. Walgreens did not immediately respond to a Reuters request for comment. ...
CME Group plans to launch Solana futures on March 17
CME Group plans to launch Solana futures on March 17
Feb 28, 2025
Feb 28 (Reuters) - CME Group ( CME ) said on Friday that it plans to roll out futures contracts on cryptocurrency Solana on March 17, pending regulatory review. The exchange said it expects to debut two contracts, one for 500 Solana coins and a micro-sized contract for 25 Solana. If the products get the regulatory stamp of approval, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved